Results with allo-SCT in patients with relapsed/refractory HL treated with anti-PD-1, a multicenter retrospective cohort study: subcommittee of transplantation and cellular therapy (GATMO-TC) of the Argentinian Hematology Society (SAH)
Leuk Lymphoma
.
2022 Dec;63(14):3508-3510.
doi: 10.1080/10428194.2022.2123238.
Epub 2022 Sep 16.
Authors
Fernando Warley
1
,
Mariano Berro
2
,
Silvina Palmer
3
,
Martin Castro
4
,
Gonzalo Ferini
1
,
Milagros Lopez Orozco
5
,
Victoria Otero
1
,
Jorge Arbelbide
1
,
Cecilia Foncuberta
6
,
Sebastián Yantorno
7
,
Ana Basquiera
7
Affiliations
1
Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
2
Hospital Austral, Buenos Aires, Argentina.
3
Hospital Británico de Buenos Aires, Buenos Aires, Argentina.
4
Sanatorio Anchorena, Buenos Aires, Argentina.
5
Hospital Privado de Córdoba, Córdoba, Argentina.
6
Instituto Alexander Fleming, Buenos Aires, Argentina.
7
Hospital Privado Centro Medico de Cordoba, Cordoba, Argentina.
PMID:
36111702
DOI:
10.1080/10428194.2022.2123238
No abstract available
Publication types
Multicenter Study
MeSH terms
Hematology*
Hematopoietic Stem Cell Transplantation* / methods
Humans
Neoplasm Recurrence, Local / therapy
Retrospective Studies
Transplantation Conditioning / methods
Transplantation, Homologous